Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2026-04-18 @ 6:17 AM
Study NCT ID:
NCT01571635
Status:
TERMINATED
Last Update Posted:
2023-06-18
First Post:
2012-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.
Sponsor:
Celgene
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ACE-011-B-THAL-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None